Provided By PR Newswire
Last update: Apr 22, 2024
Preclinical data highlights the potential of engineered macrophage cell therapy as a treatment for liver and lung fibrosis
Novel Redirected Soluble Modulator technology has demonstrated the potential to enhance immune receptor signaling
Read more at prnewswire.com